Edwards Lifesciences (NYSE:EW) Given New $88.00 Price Target at Piper Sandler

Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Piper Sandler from $85.00 to $88.00 in a report released on Friday, Benzinga reports. Piper Sandler currently has a neutral rating on the medical research company’s stock. EW has been the subject of several other research reports. Mizuho boosted their price target on […]

Related Keywords

United States ,Mizuho ,Hokkaido ,Japan ,America ,Piper Sandler ,Edwards Lifesciences ,Scottb Ullem ,Jean Lucm Lemercier ,Capital Partners ,Edwards Lifesciences Company Profile ,Edwards Lifesciences Corporation ,Securities Exchange Commission ,Pingora Partners ,Morgan Stanley ,Riverview Trust Co ,Operose Advisors ,Turtle Creek Wealth Advisors ,Free Report ,Moderate Buy ,Get Free Report ,Exchange Commission ,Creek Wealth Advisors ,Lifesciences Corporation ,Edwards Lifesciences Daily ,Nyse Ew ,Few ,Medical ,28176e10 ,Boost Price Target ,